PortfoliosLab logoPortfoliosLab logo
HCOW vs. SMRI
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

HCOW vs. SMRI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Amplify Cash Flow High Income ETF (HCOW) and Bushido Capital US Equity ETF (SMRI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, HCOW achieves a 10.71% return, which is significantly lower than SMRI's 23.03% return.


HCOW

1D
0.33%
1M
5.12%
6M
9.66%
YTD
10.71%
1Y
23.43%
3Y*
5Y*
10Y*
ALL TIME*
10.16%

SMRI

1D
0.38%
1M
5.51%
6M
23.61%
YTD
23.03%
1Y
40.59%
3Y*
5Y*
10Y*
ALL TIME*
22.95%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$145.82K$136.25K$131.36K
$770.42K$508.81K$403.01K

HCOW vs. SMRI - Yearly Performance Comparison


2026 (YTD)202520242023
HCOW
Amplify Cash Flow High Income ETF
10.71%5.76%7.63%4.66%
SMRI
Bushido Capital US Equity ETF
23.03%17.41%19.16%6.67%

Correlation

The correlation between HCOW and SMRI is 0.80, meaning they have usually moved in the same direction, including during past declines.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.80

Correlation (All Time)
Calculated using the full available price history since Sep 20, 2023

0.83

The correlation between HCOW and SMRI has been stable across timeframes, ranging from 0.80 to 0.83 - a consistent structural relationship.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

HCOW vs. SMRI — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

HCOW
HCOW Risk / Return Rank: 7676
Overall Rank
HCOW Sharpe Ratio Rank: 6868
Sharpe Ratio Rank
HCOW Sortino Ratio Rank: 7272
Sortino Ratio Rank
HCOW Omega Ratio Rank: 6868
Omega Ratio Rank
HCOW Calmar Ratio Rank: 8787
Calmar Ratio Rank
HCOW Martin Ratio Rank: 8383
Martin Ratio Rank

SMRI
SMRI Risk / Return Rank: 9494
Overall Rank
SMRI Sharpe Ratio Rank: 9494
Sharpe Ratio Rank
SMRI Sortino Ratio Rank: 9494
Sortino Ratio Rank
SMRI Omega Ratio Rank: 9292
Omega Ratio Rank
SMRI Calmar Ratio Rank: 9595
Calmar Ratio Rank
SMRI Martin Ratio Rank: 9393
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

HCOW vs. SMRI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amplify Cash Flow High Income ETF (HCOW) and Bushido Capital US Equity ETF (SMRI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


HCOWSMRIDifference
Sharpe ratioReturn per unit of total volatility

-1.08

Sortino ratioReturn per unit of downside risk

-1.35

Omega ratioGain probability vs. loss probability

1.28

1.47

-0.18

Calmar ratioReturn relative to maximum drawdown

3.42

5.75

-2.33

Martin ratioReturn relative to average drawdown

11.36

16.88

-5.51

HCOW vs. SMRI - Sharpe Ratio Comparison

The current HCOW Sharpe Ratio is 1.56, which is lower than the SMRI Sharpe Ratio of 2.64. The chart below compares the historical Sharpe Ratios of HCOW and SMRI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

HCOW vs. SMRI - Drawdown Comparison

The maximum HCOW drawdown since its inception was -24.15%, which is greater than SMRI's maximum drawdown of -18.45%. Use the drawdown chart below to compare losses from any high point for HCOW and SMRI.


Loading charts...

Drawdown Indicators


HCOWSMRIDifference

Max Drawdown

Largest peak-to-trough decline

-24.15%

-18.45%

-5.70%

Max Drawdown (1Y)

Largest decline over 1 year

-6.29%

-6.80%

+0.51%

Current Drawdown

Current decline from peak

-0.92%

-0.51%

-0.41%

Average Drawdown

Average peak-to-trough decline

-4.73%

-2.72%

-2.01%

Ulcer Index

Depth and duration of drawdowns from previous peaks

1.89%

2.32%

-0.43%

Volatility

HCOW vs. SMRI - Volatility Comparison

Amplify Cash Flow High Income ETF (HCOW) has a higher volatility of 4.10% compared to Bushido Capital US Equity ETF (SMRI) at 3.61%. This indicates that HCOW's price experiences larger fluctuations and is considered to be riskier than SMRI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


HCOWSMRIDifference

Volatility (1M)

Calculated over the trailing 1-month period

4.10%

3.61%

+0.49%

Volatility (6M)

Calculated over the trailing 6-month period

9.13%

11.80%

-2.67%

Volatility (1Y)

Calculated over the trailing 1-year period

13.86%

15.09%

-1.23%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

17.39%

15.84%

+1.55%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

17.39%

15.84%

+1.55%

HCOW vs. SMRI - Expense Ratio Comparison

HCOW has a 0.65% expense ratio, which is lower than SMRI's 0.71% expense ratio.


Dividends

HCOW vs. SMRI - Dividend Comparison

HCOW's dividend yield for the trailing twelve months is around 11.56%, more than SMRI's 0.86% yield.


PositionTTM202520242023
HCOW
Amplify Cash Flow High Income ETF
11.56%10.88%8.13%1.99%
SMRI
Bushido Capital US Equity ETF
0.86%1.32%0.98%0.45%

Frequently Asked Questions


HCOW and SMRI have a correlation of 0.80, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

HCOW has higher volatility (4.10%) compared to SMRI (3.61%). In terms of maximum drawdown, HCOW dropped -24.15% vs SMRI's -18.45%.

On 1-year performance, SMRI leads with 40.59% vs 23.43% for HCOW. On fees, HCOW is cheaper at 0.65% per year. On volatility, SMRI has been the lower-risk option at 3.61%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 1-year period, SMRI has performed better with a 40.59% return vs 23.43%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

HCOW is cheaper with a 0.65% expense ratio, compared with 0.71% for SMRI.

HCOW has the higher dividend yield at 11.56%, compared with 0.86% for SMRI.

They also come from different issuers: Amplify and Bushido. Their fees differ too: 0.65% for HCOW and 0.71% for SMRI.

SMRI currently has the higher Sharpe Ratio (2.64 vs 1.56), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for HCOW and SMRI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer